Bleeding, Thrombosis and Vascular Biology最新文献

筛选

英文中文

Artificial intelligence, platelets and aspirin 人工智能、血小板和阿司匹林

Bleeding, Thrombosis and Vascular Biology Pub Date : 2024-03-15 DOI: 10.4081/btvb.2024.130

Giovanni De Gaetano

引用次数: 0

Blood platelets, prostaglandins and aspirin: a historical and personal rereading 血小板、前列腺素和阿司匹林：历史与个人的重读

Bleeding, Thrombosis and Vascular Biology Pub Date : 2024-03-13 DOI: 10.4081/btvb.2024.121

Giovanni De Gaetano, C. Cerletti

引用次数: 0

Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape 癌症患者的静脉血栓栓塞治疗：对不断变化的情况的思考

Bleeding, Thrombosis and Vascular Biology Pub Date : 2024-02-29 DOI: 10.4081/btvb.2024.111

Agnes Y.Y. Lee

{"title":"Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape","authors":"Agnes Y.Y. Lee","doi":"10.4081/btvb.2024.111","DOIUrl":"https://doi.org/10.4081/btvb.2024.111","url":null,"abstract":"Cancer is a leading cause of morbidity and mortality worldwide. It is also one of the strongest risk factors for venous thromboembolism (VTE), reported in approximately 20% of all cases of VTE diagnosed. The thrombotic effect of cancer and its treatments, however, is highly variable among patients and changes over the course of their cancer. Anticoagulant therapy remains the cornerstone of VTE treatment, but it is associated with a substantial rate of VTE recurrence and the potential for serious bleeding. The risk of bleeding in patients with cancer is also dependent on the cancer type and its treatments, often revealing underlying tumor invasion of mucosal or parenchymal tissues, and treatment complications such as thrombocytopenia or coagulopathy. Over the past few decades, efforts to improve the efficacy and safety of anticoagulant therapy for the treatment and prevention of cancer-associated thromboembolism have resulted in changes in the standard of practice. This evolution has been made possible largely through the development of new anticoagulants. This review will reflect on the major advances in the treatment of cancer-associated thrombosis and offer insights on how to address unmet needs in this field.","PeriodicalId":517891,"journal":{"name":"Bleeding, Thrombosis and Vascular Biology","volume":"8 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140412974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页